Health
Drug to treat OCD could reduce hospitalisation risk in Covid patients, study in Lancet says – ThePrint
The study says antidepressant fluvoxamine could reduce the production of inflammatory molecules called cytokines that can be…
New Delhi: Fluvoxamine, an antidepressant used for the treatment of major depressive disorders and obsessive-compulsive disorder (OCD), can reduce the need for hospitalisation among high-risk Covid-19 patients, according to the results of a new clinical…
Continue Reading
-
Noosa News7 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
General23 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News23 hours agoBrisbane widow’s $6 million prize home win comes with unexpected luxury
-
Noosa News8 hours agoFatal traffic crash, Noosa – Sunshine Coast